LTA and infection: Similar results were obtained by treating cells with the MLCK inhibitor, ML7, demonstrating a role for MLCK in TNF-α-, TNF-β-, TWEAK- and LIGHT-dependent HCVpp infection of polarized to HepG2 (Fig. 4e).